Advertisement

Management of Male Breast Cancer

  • Jessica C. Gooch
  • Freya SchnabelEmail author
Chapter

Abstract

Male breast cancer is rare and often presents at a more advanced stage than cancer in women. It is important to evaluate for conditions that increase exposure to estrogen and to perform genetic testing for the presence of a BRCA mutation. A man with a palpable mass should undergo imaging followed by a biopsy which will confirm the diagnosis and direct subsequent therapy. Surgical management is typically with mastectomy and sentinel node biopsy or axillary nodal dissection as appropriate. Guidelines for systemic therapy and post-mastectomy radiation mirror those for female patients.

Keywords

Male Breast Cancer BRCA2 Mastectomy 

References

  1. 1.
    Kiluk JV, et al. Male breast cancer: management and follow-up recommendations. Breast J. 2011;17(5):503–9.CrossRefGoogle Scholar
  2. 2.
    Losurdo A, et al. Controversies in clinicopathological characteristics and treatment strategies of male breast cancer: a review of the literature. Crit Rev Oncol Hematol. 2017;113:283–91.CrossRefGoogle Scholar
  3. 3.
    Society AC. Cancer facts and figures 2017. Cancer. 2017:1–74.Google Scholar
  4. 4.
    Sun H, et al. Clinicopathological characteristics and survival outcomes of male breast cancer according to race: a SEER population-based study. Oncotarget. 2017:1–11.Google Scholar
  5. 5.
    Javidiparsijani S, Rosen L, Gattuso P. Male breast carcinoma: a clinical and pathological review. Int J Surg Pathol. 2017;25(3):200–5.CrossRefGoogle Scholar
  6. 6.
    Network NCC. Breast and/or ovarian cancer genetic assessment, in NCCN guidelines Version 2. 2017.Google Scholar
  7. 7.
    Hagberg KW, et al. Impact of 5-alpha reductase inhibitors for treatment of benign prostatic hyperplasia on erectile dysfunction, treated depression, gynecomastia and breast cancer: a real world 20 year observational study. Clin Epidemiol. 2017;9:83–91.CrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Department of SurgeryNYU Langone Health, NYU Perlmutter Cancer CenterNew YorkUSA

Personalised recommendations